Validation of ApneaLink Air Home Sleep Testing in the Diagnosis of Obstructive Sleep Apnea in Adolescent Children
Sleep Apnea, Obstructive
About this trial
This is an interventional diagnostic trial for Sleep Apnea, Obstructive
Eligibility Criteria
Inclusion Criteria:
- Patients presenting with symptoms of OSA needing a sleep study
- Patients between the ages of 12 and 17 years, inclusive
Exclusion Criteria:
- Patients less than 12 years old
- Patients 18 years old or older
- Children with syndromes or congenital disease including Down Syndrome, Prader-Willi syndrome, children with craniofacial disorders, and finally children with congenital heart disease or pulmonary hypertension
Sites / Locations
- Rady Children's Hospital
Arms of the Study
Arm 1
Experimental
ApneaLink Air
Half of the participants will undergo HST no greater than one week prior to their in-laboratory PSG, while the other half will undergo HST no greater than one week following their in laboratory PSG. All participants will also undergo their HST concurrent to their in-laboratory PSG. The rational for splitting participants in these two groups is to equally distribute the effects of the first night evenly, in which the sleep architecture including reduced total rapid eye movement (REM) sleep time can vary during the first ever sleep study. As the HST will be compared to the in-lab PSG, we would like to evenly distribute this effect by having two groups of ten participants.